Treatment of metastatic urachal adenocarcinoma in a young woman: A case report

Cases Journal

Volumn 2, Issue 12, 2009, Pages

  Tazi, Elmehdi ^a   Lalya, Issam ^a   Tazi, Mohammed Fadl ^b   Ahallal, Youness ^a   M'Rabti, Hind ^a   Errihani, Hassan ^a  

^a NATIONAL INSTITUTE OF ONCOLOGY   (Morocco)

^b HASSAN II UNIVERSITY HOSPITAL   (Morocco)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; FOLINIC ACID; IRINOTECAN;

ADULT; ANAMNESIS; ARTICLE; BLADDER CARCINOMA; CANCER CHEMOTHERAPY; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CYSTOSCOPY; DIARRHEA; DRUG DOSE REDUCTION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LABORATORY TEST; LUNG METASTASIS; METASTASIS; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; TREATMENT RESPONSE; URACHAL ADENOCARCINOMA;

EID: 77953371400     PISSN: 17571626     EISSN: None     Source Type: Journal    
DOI: 10.1186/1757-1626-2-9145     Document Type: Article

References (16)

1. Wright JL, Porter MP, Li CI, Lange PH, Lin DW: Differences in survival among patients with urachal and nonurachal adenocarcinomas of the bladder. Cancer 2006, 107:721-728.
2. Sheldon CA, Clayman RV, Gonzalez R, Williams RD, Fraley EE: Malignant urachal lesions. J Urol 1984, 131:1-8.
3. Siefker-Radtke A: Urachal carcinoma: surgical and chemotherapeutic options. Expert Rev Anticancer Ther 2006, 6:1715-1721.
4. Ashley RA, Inman BA, Sebo TJ, Leibovich BC, Blute ML, Kwon ED, Zincke H: Urachal carcinoma: clinicopathologic features and long-term outcomes of an aggressive malignancy. Cancer 2006, 107:712-720.
5. Pinthus JH, Haddad R, Trachtenberg J, Holowaty E, Bowler J, Herzenberg AM, Jewett M, Fleshner NE: Population based survival data on urachal tumors. J Urol 2006, 175:2042-2047.
6. Siefker-Radtke AO, Gee J, Shen Y, Wen S, Daliani D, Millikan RE, Pisters LL: Multimodality management of urachal carcinoma: the MD Anderson Cancer Center experience. J Urol 2003, 169:1295-1298.
7. Herr HW, Bochner BH, Sharp D, Dalbagni G, Reuter VE: Urachal carcinoma: contemporary surgical outcomes. J Urol 1997, 178:74-78.
8. Herr HW: Urachal carcinoma: the case for extended partial cystectomy. J Urol 1994, 151:365-366.
9. Kawakami S, Kageyama Y, Yonese J, Fukui I, Kitahara S, Arai G, Hyouchi N, Suzuki M, Masuda H, Hayashi T, Okuno T, Kihara K: Successful treatment of metastatic adenocarcinoma of the urachus: report of 2 cases with more than 10-year survival. Urology 2001, 58:462.
10. Logothetis CJ, Samuels ML, Ogden S: Chemotherapy for adenocarcinomas of bladder and urachal origin: 5-fluorouracil, doxorubicin, and mitomycin-C. Urology 1985, 26:252-255.
11. Ichiyanagi O, Sasagawa I, Suzuki Y, Iijima Y, Kubota Y, Nakada T, Arai S: Successful chemotherapy in a patient with recurrent carcinoma of the urachus. Int Urol Nephrol 1998, 30:569-573.
12. Quilty PM: Urachal carcinoma: a response to chemotherapy. Br J Urol 1987, 60:372.
13. Rothenberg ML, et al.: Phase I and pharmacokinetic trial of weekly CPT-11. J Clin Oncol 1993, 11:2194-2204.
14. Hurwitz HI, Fehrenbacher L, Hainsworth JD, Heim W, Berlin J, Holmgren E, Hambleton J, Novotny WF, Kabbinavar F: Bevacizumab in combination with fluorouracil and leucovorin: an active regimen for first-line metastatic colorectal cancer. J Clin Oncol 2005, 23:3502-3508.
15. Pozzo C, Barone C, Szanto J, Padi E, Peschel C, Bükki J, Gorbunova V, Valvere V, Zaluski J, Biakhov M, Zuber E, Jacques C, Bugat R: Irinotecan in combination with 5-fluorouracil and folinic acid or with cisplatin in patients with advanced gastric or esophageal-gastric junction adenocarcinoma: results of a randomized phase II study. Ann Oncol 2004, 15:1773-1781.
16. Bouche O, Raoul JL, Bonnetain F, Giovannini M, Etienne PL, Lledo G, Arsène D, Paitel JF, Guérin-Meyer V, Mitry E, Buecher B, Kaminsky MC, Seitz JF, Rougier P, Bedenne L, Milan C, Fédération Francophone de Cancérologie Digestive Group: Randomized multicenter phase II trial of a biweekly regimen of fluorouracil and leucovorin (LV5FU2), LV5FU2 plus cisplatin, or LV5FU2 plus irinotecan in patients with previously untreated metastatic gastric cancer: a Federation Francophone de Cancerologie Digestive Group Study - FFCD 9803. J Clin Oncol 2004, 22:4319-4328.